ArticleFrontiers in endocrinology2025

Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus.

Toru Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.